Aviceda Therapeutics, Inc.

Form D Filings

Location
Cambridge, MA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001824762
Previous Names
Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
1/13/2025 Equity $74,999,940 $74,999,940 $207,499,882 $132,499,942 12/17/2024 1/10/2025 D/A 000182476225000001
11/22/2024 Equity $0 $0 $200,000,000 $200,000,000 11/22/2024 D 000182476224000002
5/31/2024 Equity, Option to Acquire $18,899,969 $18,899,969 $27,700,000 $8,800,031 5/17/2024 5/31/2024 D 000182476224000001
5/19/2023 Equity $15,610,000 $15,610,000 $15,610,000 $0 5/5/2023 5/19/2023 D 000182476223000002
3/28/2022 Equity $8,398,584 $8,398,584 $26,200,000 $17,801,416 3/11/2022 3/28/2022 D 000182476222000001
8/12/2021 Debt, Other $1,950,000 $1,950,000 $1,950,000 $0 7/14/2021 8/11/2021 D 000182476221000001
9/16/2020 Other $4,250,000 $4,250,000 $4,250,000 $0 2/26/2020 9/16/2020 D 000182476220000001